Ann: CBCF funding to support deoxymab brain cancer development, page-28

Thanks mattyedw. The "beauty" of PAB is that there are TWO mysteries attached to it. One is reasonably predictable, live clinical trials, but, the potential elephant in the room is the (strong, but unpredictable) possibility of PAB never getting to those clinical trials and be swallowed up by big pharma. The alternative to that would be big pharma buying in big time to get the rights to manufacture and label the product in their name.
That scenario could happen ANY day?/ So, IF that does happen, many people who are only waiting on the clinical trials will be caught short, big time, becaue huge maoney could be involved with such a product. 2.5 cents would be ridiculous.
Patience is not always a virtue.